EPO and chronic kidney disease: On the other hand, EPO effects seem to be context-dependent, as EPO produced in brain, liver, spleen, lung and testis (where EPO mRNA was detected) is unable to substitute for renal EPO in chronic kidney disease, and brain EPO seems to act locally as neuroprotector (Jelkmann, 2011).